HU172058B - Sposob poluchenija gamma- laktonov 3-al'fa,5-al'fa-digidroksi-2-beta-skobka-aril-alkenil-skobka zakryta-ciklopentil-uksusnojj kisloty - Google Patents

Sposob poluchenija gamma- laktonov 3-al'fa,5-al'fa-digidroksi-2-beta-skobka-aril-alkenil-skobka zakryta-ciklopentil-uksusnojj kisloty

Info

Publication number
HU172058B
HU172058B HU73PI00000482A HUPI000482A HU172058B HU 172058 B HU172058 B HU 172058B HU 73PI00000482 A HU73PI00000482 A HU 73PI00000482A HU PI000482 A HUPI000482 A HU PI000482A HU 172058 B HU172058 B HU 172058B
Authority
HU
Hungary
Prior art keywords
alpha
bracket
cyclipenthyl
dihydroxy
alkenyl
Prior art date
Application number
HU73PI00000482A
Other languages
English (en)
Hungarian (hu)
Inventor
Michael R Johnson
Hans-Juergen E Hess
Thomas K Schaaf
Jasjit S Bindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU172058B publication Critical patent/HU172058B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • C07F9/4059Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B63SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63BSHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B2211/00Applications
    • B63B2211/02Oceanography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HU73PI00000482A 1972-07-13 1973-07-12 Sposob poluchenija gamma- laktonov 3-al'fa,5-al'fa-digidroksi-2-beta-skobka-aril-alkenil-skobka zakryta-ciklopentil-uksusnojj kisloty HU172058B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27122072A 1972-07-13 1972-07-13

Publications (1)

Publication Number Publication Date
HU172058B true HU172058B (hu) 1978-05-28

Family

ID=23034697

Family Applications (4)

Application Number Title Priority Date Filing Date
HU73PI00000482A HU172058B (hu) 1972-07-13 1973-07-12 Sposob poluchenija gamma- laktonov 3-al'fa,5-al'fa-digidroksi-2-beta-skobka-aril-alkenil-skobka zakryta-ciklopentil-uksusnojj kisloty
HU73PI00000387A HU171156B (hu) 1972-07-13 1973-07-12 Sposob poluchenija omega-aril-nor-prostaglandinov
HU73PI00000481A HU171946B (hu) 1972-07-13 1973-07-12 Sposob poluchenija proizvodnykh 11-al'fa, 15-al'fa-tetragidropiraniloksi-omega-prostaglandina
HU73PI00000480A HU171158B (hu) 1972-07-13 1973-07-12 Sposob poluchenija slozhnykh di-efirov alkilovago rjada i 2-okso-omega-aralkil-fosfonojj kisloty

Family Applications After (3)

Application Number Title Priority Date Filing Date
HU73PI00000387A HU171156B (hu) 1972-07-13 1973-07-12 Sposob poluchenija omega-aril-nor-prostaglandinov
HU73PI00000481A HU171946B (hu) 1972-07-13 1973-07-12 Sposob poluchenija proizvodnykh 11-al'fa, 15-al'fa-tetragidropiraniloksi-omega-prostaglandina
HU73PI00000480A HU171158B (hu) 1972-07-13 1973-07-12 Sposob poluchenija slozhnykh di-efirov alkilovago rjada i 2-okso-omega-aralkil-fosfonojj kisloty

Country Status (25)

Country Link
JP (4) JPS5241257B2 (xx)
AR (2) AR209064A1 (xx)
AT (1) AT367033B (xx)
BE (1) BE802231A (xx)
CA (1) CA1041495A (xx)
CH (1) CH593254A5 (xx)
CS (1) CS201027B2 (xx)
DD (2) DD109210A5 (xx)
DE (1) DE2334945A1 (xx)
ES (4) ES416865A1 (xx)
FI (1) FI57583C (xx)
FR (1) FR2192834B1 (xx)
GB (1) GB1446341A (xx)
HU (4) HU172058B (xx)
IE (1) IE37909B1 (xx)
IL (2) IL42691A (xx)
IN (1) IN138789B (xx)
LU (1) LU68015A1 (xx)
NL (1) NL7309792A (xx)
NO (2) NO143741C (xx)
PH (1) PH11461A (xx)
SE (3) SE7705946L (xx)
SU (4) SU644384A3 (xx)
YU (1) YU187773A (xx)
ZA (1) ZA734769B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
DE2416193C2 (de) 1974-04-03 1985-08-14 Hoechst Ag, 6230 Frankfurt Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie ihre Verwendung als cytoprotektives Mittel
DE2463432C2 (xx) * 1974-04-03 1987-06-19 Hoechst Ag, 6230 Frankfurt, De
ZA747723B (en) * 1974-12-11 1976-11-24 Pfizer 11-desoxy-15-substituted-omega-pentanor prostaglandins
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
GB8329559D0 (en) * 1983-11-04 1983-12-07 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins preparations
SE9002596D0 (sv) * 1990-08-08 1990-08-08 Pharmacia Ab A method for synthesis of prostaglandin derivatives
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US6602900B2 (en) 1992-09-21 2003-08-05 Allergan, Inc. Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
KR100578616B1 (ko) * 2004-07-23 2006-05-10 한미약품 주식회사 D-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법
UA121108C2 (uk) * 2013-12-13 2020-04-10 Аллерган, Інк. Тверді форми альфа,омега-дизаміщеної дигідроксициклопентильної сполуки та способи її отримання і застосування

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
IL42373A (en) * 1972-06-02 1977-08-31 Pfizer Oxaprostagliandins and their preparation

Also Published As

Publication number Publication date
IL50308A0 (en) 1976-10-31
GB1446341A (en) 1976-08-18
FI57583C (fi) 1980-09-10
JPS5293753A (en) 1977-08-06
SE7705946L (sv) 1977-05-20
ZA734769B (en) 1974-06-26
YU187773A (en) 1982-02-25
IL42691A (en) 1979-07-25
SU584791A3 (ru) 1977-12-15
JPS52122349A (en) 1977-10-14
SU645563A3 (ru) 1979-01-30
AT367033B (de) 1982-05-25
ES437037A1 (es) 1977-01-01
ES437039A1 (es) 1977-01-01
SE7705947L (sv) 1977-05-20
AU5778473A (en) 1975-01-09
CA1041495A (en) 1978-10-31
FI57583B (fi) 1980-05-30
HU171156B (hu) 1977-11-28
DE2334945A1 (de) 1974-03-07
IE37909L (en) 1974-01-13
NO143741B (no) 1980-12-29
FR2192834B1 (xx) 1979-04-06
AR209064A1 (es) 1977-03-31
HU171158B (hu) 1977-11-28
HU171946B (hu) 1978-04-28
JPS5241257B2 (xx) 1977-10-17
LU68015A1 (xx) 1974-01-21
CH593254A5 (xx) 1977-11-30
NO143741C (no) 1981-04-08
NL7309792A (xx) 1974-01-15
IE37909B1 (en) 1977-11-09
ATA620773A (de) 1981-10-15
FR2192834A1 (xx) 1974-02-15
DD116459A5 (xx) 1975-11-20
JPS5297958A (en) 1977-08-17
SU644384A3 (ru) 1979-01-25
ES416865A1 (es) 1976-03-01
IL42691A0 (en) 1973-10-25
SE7705945L (sv) 1977-05-20
AR214383A1 (es) 1979-06-15
NO144830C (no) 1981-11-18
JPS4992053A (xx) 1974-09-03
CS201027B2 (en) 1980-10-31
NO144830B (no) 1981-08-10
ES437038A1 (es) 1977-01-01
IN138789B (xx) 1976-04-03
PH11461A (en) 1978-02-01
SU645564A3 (ru) 1979-01-30
NO743492L (no) 1974-01-15
BE802231A (fr) 1974-01-14
DD109210A5 (xx) 1974-10-20

Similar Documents

Publication Publication Date Title
HU171819B (hu) Sposob poluchenija proizvodnykh slozhnykh di-efirov 2-okso-3-fenoksi propil-fosfonnojj kisloty s alkanolami
EG11278A (en) Process for preparing prostanoic acid derivatives
HU172058B (hu) Sposob poluchenija gamma- laktonov 3-al'fa,5-al'fa-digidroksi-2-beta-skobka-aril-alkenil-skobka zakryta-ciklopentil-uksusnojj kisloty
HU167527B (en) Process for producing 7-isocyanato-3-methyl-3-cefem-4-carboxylic acid derivatives
YU332373A (en) Process for obtaining pregnanic acid derivatives
YU35451B (en) Process for obtaining pregnanic acid derivatives
HU172069B (hu) Sposob poluchenija proizvodnykh 1-skobka-3-dvojjnozamehhennykh-fosfono-tioureido-skobka zakryta-2-skobka-3-zamehhennykh-ureido- ili -tioureido-skobka zakryta-benzolov
CA1033368A (en) PROCESS FOR PRODUCING .alpha.-SULFOPHENYLACETIC ACID DERIVATIVES
HU170406B (en) Process for producing azetidine-2-sulfenic acid silis-esters
CA1018184A (en) Process for preparing trans-chrysanthemic acid
YU64473A (en) Process for obtaining thiocarbamic acid derivatives
YU179579A (en) Process for preparing indole-carboxylic acid derivatives
HU172016B (hu) Sposob poluchenija proizvodnykh skobka-7-zamehhennykh-skobka zakryta-fenilglicinamido-3-zamehhennykh-3-cefem-4-karbonovykh kislot
HU167876B (en) Process for producing 9-10-secoestrane derivatives
HU173381B (hu) Sposob poluchenija proizvodnykh karboksi-ciklopropanov
CA945564A (en) Process for producing 5-halo-4-aminosalicyclic acid derivatives
IL43123A0 (en) Process for the manufacture of 7-amino-3-cephem-4-carboxylic acid derivatives
CA1004224A (en) Method for producing new sulfamylbenzoic acid derivatives
CA1034115A (en) Process for producing desacetoxycephalosporin derivatives
AU476254B2 (en) Process for producing chromone derivatives
HU171722B (hu) Sposob poluchenija proizvodnykh 7-kvadratnaja skobka-d-al'fa-amino-al'fa-skobka-4-gidroksifenil-skobka zakryta-acetamido-kvadratnaja skobka zakryta-3-metil-3-cefem-4-karbonovykh kislot
CS184873B1 (en) Method for producing 1,8-naphtyridine derivatives
CA938617A (en) Process for producing peracetic acid
YU36701B (en) Process for obtaining as-triazinoz5,6-ccquinoline derivatives
ZA735014B (en) Process for producing new nitrofurane derivatives